reference/3961322

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3961322

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	635
issn	1573-0646 0167-6997
issueIdentifier	4
pageRange	625-635
publicationName	Investigational New Drugs
startingPage	625
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6613c5d7c495e3812b0d2c6e8f666996 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_072af4e327096dfeb6d30f9a3787a39e
bibliographicCitation	Rahaman MH, Yu Y, Zhong L, Adams J, Lam F, Li P, Noll B, Milne R, Peng J, Wang S. CDKI-73: an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemia. Invest New Drugs. 2019 Aug;37(4):625–35. doi: 10.1007/s10637-018-0661-2. PMID: 30194564.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0fa44b9073a29471a64bc9dbe1ecc309 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae2487bde80538ea57fee97b93dd1bdc http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6225-5525 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_541846dc7cc1027a412a15b30d200c89 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db36f2d99a96b3a5a89bb734e6549b1b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_225fc049387026c86b642fccd862fddd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d5c34727037ef2cf3501906d99925f7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cb90041130e741b5a18461201f95fb9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5522c69ec97bb02533ea5e7fd8ae752a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d6a513b69a25c88319023f3d33cad74
date	2018-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/30194564 https://doi.org/10.1007/s10637-018-0661-2
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4372 https://portal.issn.org/resource/ISSN/0167-6997 https://portal.issn.org/resource/ISSN/1573-0646
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/
title	CDKI-73: an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemia
discusses	http://id.nlm.nih.gov/mesh/M0230514 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M000608377 http://id.nlm.nih.gov/mesh/M0478975 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0442145 http://id.nlm.nih.gov/mesh/M0020790
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9476 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9c79da2a86f6c595a38b838a7a321b92 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71561915 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8908d9f016f678ac2f17eeac90bb5212 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9710 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9731 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4f3366af2ce1555e259faab86aad3bef http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8306 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8300 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0e75b04b99ad7f9547bbdf30bf933fe9 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID472319196

Total number of triples: 54.